World Market for Cancer Vaccines 2007-2012

Released on = April 30, 2007, 9:53 pm

Press Release Author = Bharat Book Bureau

Industry = Pharmaceuticals

Press Release Summary = These are just some of the news headlines that have seen the
world cancer vaccine market turned on its head.

Press Release Body = The benefits are unquestionable, the costs of the drugs
however may yet see take-up slow. How will this effect your company? This report
will tell you.

There are two types of cancer vaccines :

Prophylactic cancer vaccines, designed to prevent the development of cancer, they
are given to healthy subjects to prevent infection with cancer-causing viruses
Therapeutic cancer vaccines, designed to treat existing cancers, they are given to
cancer patients to stimulate the immune system into recognizing and destroying their
existing cancer
Previously the cancer vaccine market has consisted of HBV (hepatitis B virus)
vaccines to prevent liver cancer. 2006 saw the launch of Gardasil the first vaccine
against HPV (human papilloma virus) to protect against cervical cancer. Another HPV
vaccine, Cervarix, is due to be launched in 2007. These two vaccines are together
predicted to generate sales of more than $4bn in 2012, which could see them becoming
the top selling vaccines. Their success could lead a growth in the cancer vaccines
market, resulting in it being worth 7 times what it is today. Will you be able to
capture your share of the market place?

Therapeutic cancer vaccines, designed to stimulate the immune system into killing
existing cancers, also look likely to soon achieve commercial success, after much
investment into their research and development. The first therapeutic cancer vaccine
is expected to be launched in 2007, with a number of others predicted to obtain
licenses in the next few years. Hw will this effect current cancer drugs and
treatments? Understand today.

The report gives an overview of the current and potential market for cancer
vaccines, in particular concentrating on the following aspects of cancer vaccines :

Technologies utilised by cancer vaccines
Key players in cancer vaccines
Revenue forecasts for prophylactic cancer vaccines
Therapeutic cancer vaccines likely to achieve commercial success
Drivers and opportunities in the cancer vaccine market
Restraints and threats in the cancer vaccine market
The cancer vaccine pipeline
Why you must by this report:

The pharmaceutical industry has been seeking the next blockbuster drug, yet it
appears as though these might not be as profligate as they have been in the past.
However, the addiction treatment markets hold promise, particularly for the
development of products for nicotine addiction and the treatment of obesity. This
report analyses the current situation in the market and assesses the potential of
the products that are currently in the development pipeline. A comprehensive
analysis of the addiction treatment market from 2006-2011 outlines the potential of
the market. Visiongain expects to see the development of at least two multi-billion
dollar markets. You and your company should be part of this market, and you could be
by placing your order immediately.

Unique benefits to you when you order this report :

- Full searchable report when you buy the company or corporate editions
- Immediate access through our exclusive Reading Room
- You can access your report whichever country you are in without using harddrive space
- Primary research throughout. You will not find this information anywhere else
- Report stored in your reading room for ever
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables

For more information, Please visit : http://www.bharatbook.com/detail.asp?id

Web Site = http://www.bharatbook.com

Contact Details = Bharat Book Bureau
207, Hermes Atrium, Navi Mumbai - 400 614, India.
Ph. : +91-(022)-2757 8668 or +91-(022)-2757 9131
email : bharatbook@gmail.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •